University of Illinois at Chicago
Announcement of a Sole Source Purchase
Vendor: Medtronic/Advance Energy, Portsmouth, NH
Amount: An estimated $1,035,000
An estimated start date of 2/13/2017 through 2/12/2020, 36 months
The University award process may be delayed up to thirty days as this award goes through a state approval process.
The hearing has been cancelled since no vendors registered to attend or submitted comments regarding this notice.
First published Friday, January 20, 2017
The University awarded a contract for Medtronic's Aquamantys Transcollation Technology to Medtronic/Advance Energy, Portsmouth, NH, for an estimated $1,035,000.
Purchase of Medtronic's Aquamantys Transcollation Technology and ancillary products are needed to achieve hemostasis during hip or knee surgery.
The Aquamantys system uses patented Transcollation technology which is a bipolar sealer that delivers RF (radiofrequency energy) and saline simultaneously to a surgical field in order to provide hemostasis or sealing across an exposed tissue or bone surface. The process heats tissues to around 100 degrees centigrade, nearly 200°C less than conventional electrocautery devices. By maintaining the heating of the tissue near 100 degrees centigrade it will shrink the collagen in the walls of the tissue vessels and will produce less smoke and without the charring associated with other methods.
The Aquamantys SBS 5.0 Sheathed Bipolar Sealer gives spine surgeons the ability to optimize speed and continuity in surgical cases by providing hemostatis sealing capabilities for both incised soft tissue (e.g., cut muscle) and epidural veins with a single device. Like other devices in the Aquamantys line, the SBS 5.0 uses Transcollation® technology, a combination of radiofrequency energy and saline that has been shown to reduce blood loss and improve visualization when used during spine procedures. Reductions in blood loss during surgery have been linked to reduced blood transfusion rates and decreased surgical time.
We are confident that no other product offers these unique results that is, reduction of blood loss and visual results that Aquamantys offers.
The University has determined that this purchase is only economically available from this source because the item or service is copyrighted or patented and is not available except from the holder of the copyright or patent.
For additional information, contact:
State Purchasing Officer - Aaron M. Finder
We will hold a public hearing at the date, time and location specified below, if we
receive a request to testify regarding the sole source determination. We will also
hold a hearing if any vendor submits a signed statement showing the capability to
provide the stated supplies/services at or below the amount indicated.
The public hearing allows any interested party the opportunity to testify for or against
the sole source determination as described in this notice. The purpose of the hearing
is to receive information from the public in a reasonable manner. Formal rules of evidence
will not apply. The hearing officer will produce minutes of the hearing and may record
it in order to aid in the production of the minutes. After conclusion of the hearing we
will decide whether the sole source determination was appropriate.
We must receive any request to testify and any vendor statement no later than the
registration date and time indicated below. If we do not receive a timely request or statement, we will not hold
the hearing. We reserve the right to cancel the procurement prior to any scheduled hearing.
Please confirm the status of the hearing with the Hearing Contact.
February 8, 2017
401 S. Spring Street
Date, time, and location are
subject to change and/or cancellation. It is the responsibility of potential
participants to confirm these details prior to attendance.
February 3, 2017
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.